| Literature DB >> 29468946 |
Nicholas J Haley1, Jürgen A Richt2, Kristen A Davenport3, Davin M Henderson3, Edward A Hoover3, Matteo Manca4, Byron Caughey5, Douglas Marthaler2, Jason Bartz6, Sabine Gilch7.
Abstract
Amplification assays for transmissible spongiform encephalopathies have been in development for close to 15 years, with critical implications for the postmortem and antemortem diagnosis of human and animal prion diseases. Little has been published regarding the structured development, implementation and interpretation of experiments making use of protein misfolding cyclic amplification (PMCA) and real time quaking-induced conversion (RT-QuIC), and our goal with this Perspectives manuscript is to offer a framework which might allow for more efficient expansion of pilot studies into diagnostic trials in both human and animal subjects. This framework is made up of approaches common to diagnostic medicine, including a thorough understanding of analytical and diagnostic sensitivity and specificity, an a priori development of amplification strategy, and an effective experimental design. It is our hope that a structured framework for prion amplification assays will benefit not only experiments seeking to sensitively detect naturally-occurring cases of prion diseases and describe the pathogenesis of TSEs, but ultimately assist with future endeavors seeking to use these methods more broadly for other protein misfolding disorders, including Alzheimer's and Parkinson's disease.Entities:
Keywords: Creutzfeldt-Jakob disease; PMCA; RT-QuIC; amplification; chronic wasting disease; prion; scrapie
Mesh:
Substances:
Year: 2018 PMID: 29468946 PMCID: PMC6016519 DOI: 10.1080/19336896.2018.1443000
Source DB: PubMed Journal: Prion ISSN: 1933-6896 Impact factor: 3.931